3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
12
Recruiting
9
Completed
8
Terminated
5
Not yet recruiting
3
Active not recruiting
2
Withdrawn
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
1
Interventions
pembrolizumab
438
Carboplatin
321
Nivolumab
293
Cyclophosphamide
285
Specimen Handling
257
Paclitaxel
249
Magnetic Resonance Spectroscopy
249
Cisplatin
248
Radiotherapy
218
Dexamethasone
183
Gemcitabine
177
Biopsy
177
durvalumab
169
atezolizumab
149
Doxorubicin
140
Rituximab
138
Lenalidomide
135
Docetaxel
131
Ipilimumab
130
Bevacizumab
128
Radiation
121
Capecitabine
117
Etoposide
116
Oxaliplatin
114
Fluorouracil
110
Pemetrexed
109
Radiosurgery
108
fludarabine
106
venetoclax
102
Prednisone
97
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Interventional
×
TP protocol
×
Clear all
NCT06143748
2026-04-23
EC-CRT-006
Sun Yat-sen University
Phase 2
Active not recruiting
46 enrolled
NCT05520619
2024-11-18
EC-CRT-002
Sun Yat-sen University
Phase 2
Active not recruiting
114 enrolled